Recent research suggests that patients with mutations in the EMD gene can present solely as a cardiac phenotype, termed cardiac emerinopathy, with probable association with left ventricular noncompaction (LVNC) and an increased risk of thromboembolic events [48]. The gene discussed is EMD; the disease is left ventricular noncompaction.